(4-Chloro-1-methyl-1H-pyrazol-3-yl)methanesulfonyl chloride, 97.0%, 100mg

2-Methylthiobenzamide, 98.0%, 5g

3-(4-Aminophenyl)-2-phenylpropanoic acid, 97%, 250mg

(E)-4-Hexen-3-one>98.0%(GC)5mL

1-(5-amino-3-methyl-1H-pyrazol-4-yl)ethanone hydrochloride, 95.0%, 5g

4-Chloro-N-methylpyridine-2-carboxamide, 97.0%, 1kg

(R)-4-Hydroxy-N,N-diphenylpent-2-ynamide, 95.0%, 5g

Methyl (R)-2-amino-4-((tert-butoxycarbonyl)amino)butanoate hydrochloride, 98%, 1g

(3-Formyl-4-hydroxyphenyl)boronic acid, 98%, 1g

(4-Cyano-3-methylphenyl)boronic acid, 95.0%, 1g

Seringue microlitre GASTIGHT® série 1000, 10,0 ml, 1010 TLL, 1 pièce

(E,E)-1,4-Bis[4-[bis(4-methoxyphenyl)amino]styryl]benzene>98.0%(HPLC)(N)25g

Chlorhydrate d'ester méthylique de L-tert-leucine, min 98 %, pour la biochimie, 500 mg